Veris Director Invests $143K in Company Stockby Mark Eisenberg 22.06.2024Nori Gerardo Lietz buys 10,000 shares in Veris Residential, Inc., reflecting confidence in the REIT's future amidst key strategy shifts ...
Stephany Kirkpatrick on Advancing Inclusivity in Financeby Mark Eisenberg 22.06.2024Stephany Kirkpatrick's Orum pushes for financial inclusivity with fast, reliable payments, aiming to end financial barriers for underserved communities.
AI Transforming Lending at Horicon Bank: Chrissy Oelke’s Visionby Lilu Anderson 22.06.2024Horicon Bank's AI transformation boosts customer engagement, maximizes service efficiency, and secures growth, led by AVP Chrissy Oelke's expertise.
StanChart Enters ETH Spot Trading; ChatGPT Forecasts $6K-$9Kby John Darbie 22.06.2024"Standard Chartered enters ETH spot trading, predicts ETH at $6K-$9K by 2025, as global bank manages $822B in assets. Read ...
Sony Slashes VR Investment: Only Two Games in the Pipelineby Mark Eisenberg 21.06.2024Sony reportedly cuts VR game investments; only two first-party VR games in PSVR2 pipeline, casting doubts on future support and ...
ICC Arbitration’s Rise in Colombia: Project Finance Impactby Mark Eisenberg 21.06.2024"Explore why arbitration is the top choice for resolving disputes in Colombia's 4G and 5G projects, and its growing future ...
Bidders Line Up for HSBC’s German Fund Units: Sourcesby Mark Eisenberg 21.06.2024HSBC's fund administration and custody units in Germany attract bidders like State Street, BNP Paribas, and Caceis, with valuations over ...
DTX Exchange and Cardano: Post-Ethereum ETF Boom?by John Darbie 21.06.2024Discover why DTX Exchange could surge after Ethereum Spot ETF approval and explore Cardano's price prediction for June 2024 in ...
Micron Technology: Analysts Bullish Despite Stock Dipby Lilu Anderson 21.06.2024Micron's semiconductor fab project in Syracuse faces delays due to endangered bats and wetlands, pushing construction to 2025 despite state ...
ADC Therapeutics Director Azelby Sells Shares Amid Price Target Cutby Mark Eisenberg 20.06.2024Robert Azelby sells $20,215 in ADC Therapeutics shares for tax reasons; holds 53,005 shares. Investors eye insider actions for future ...